Chemical Compound
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8R)-; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8R)- (9CI); 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (R)-; (8R)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 7-Deoxyadriamycin aglycone; 7-Deoxyadriamycinone; 7-Deoxydoxorubicin aglycone; 7-Deoxydoxorubicinone; 7-Deoxyepirubicin aglycone; NSC 270536
CAS Registry Number
38554-25-5
Primary record
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8R)-; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8R)- (9CI); 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (R)-; (8R)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 7-Deoxyadriamycin aglycone; 7-Deoxyadriamycinone; 7-Deoxydoxorubicin aglycone; 7-Deoxydoxorubicinone; 7-Deoxyepirubicin aglycone; NSC 270536
- 库存
- 552 克
- 纯度
- 99.2 %
- CAS
- 38554-25-5
化合物标识与属性
- CAS
- 38554-25-5
- PubChem CID
- 83958
- SMILES
- COC1=CC=CC2=C1C(=O)C3=C(C4=C(C[C@](CC4)(C(=O)CO)O)C(=C3C2=O)O)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)CC3
名称与同义词
- 7-Deoxydoxorubicinone
- 7-Deoxyadriamycin aglycone
- 7-Deoxydoxorubicin aglycone
- 7-Deoxyadriamycinone
- Adriamycin 7-deoxyaglycone
- 7-Deoxy Doxorubicin Aglycone
- Doxorubicin 7-deoxyaglycone
- 7-Deoxyepirubicin Aglycone
- 38554-25-5
- AC1Q5HJN
- RefChem:546314
- UNII-VB2YU5128G
- VB2YU5128G
- 7-Deoxydoxorubicin aglycon
- AC1L36IJ
- QHGFPRZWWKUHKF-OAQYLSRUSA-N
- 7-Deoxy Doxorubicin Aglycone (> 75%)
- CHEMBL3508144
- NSC 270536
- SCHEMBL12228502
- SCHEMBL30407679
- NSC-270536
- CID83958
- ZINC5734148
- AR-1G5785
- C21-H18-O8
- 7-Deoxy Doxorubicin Aglycone (approxmately 75%)
- 7-Deoxy Doxorubicin Aglycone (> 75%)
- J127.339F
- FT-0665801
- G91389
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (R)-
- (9R)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- Q27291737
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8R)-
- (8R)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
- 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,(r)-
- 8-Glycoloyl-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydro-5,12-naphthacenedione #
- (8R)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- (8R)-7,8,9,10-Tetrahydro-6,8alpha,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
- (R)-1-Methoxy-6,8alpha,11-trihydroxy-8beta-(hydroxyacetyl)-7,8,9,10-tetrahydro-5,12-naphthacenedione
- 40461-97-0
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8R)-; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8R)- (9CI); 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (R)-; (8R)-7,8,9,10-Tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 7-Deoxyadriamycin aglycone; 7-Deoxyadriamycinone; 7-Deoxydoxorubicin aglycone; 7-Deoxydoxorubicinone; 7-Deoxyepirubicin aglycone; NSC 270536